Analysis of the latest official instructions and correct medication guide for donepezil (Aricept)

Donepezil (Donepezil), trade name Aricept (Aricept), is a central nervous system drug mainly used to treat patients with Alzheimer's disease (AD) and other mild to moderate dementia symptoms. Its main mechanism of action is to selectively inhibit acetylcholinesterase (AChE), thereby increasing the concentration of acetylcholine in the brain, improving nerve signal conduction, and helping to alleviate patients' symptoms of cognitive impairment, memory decline, and decline in daily life abilities. Donepezil is a cholinergic enhancer that indirectly enhances patients' learning and memory abilities by improving neurotransmitter function. However, it should be noted that it cannot cure Alzheimer's disease or prevent the progression of the disease. It only relieves symptoms and improves function.

According to the latest official instructions, donepezil is suitable for the treatment of patients with mild to moderate Alzheimer's disease. The starting dose for adults is usually 5 mg once daily, and it is recommended to take it orally after dinner to reduce the incidence of gastrointestinal discomfort. In clinical use, if the patient tolerates it well, it can be increased to 10 mg/day after 4 to 6 weeks. In some clinical trials and special patient situations, doctors can adjust the dose to a maximum of 20mg per day based on individual tolerance, but this must be done under the guidance of a professional doctor to ensure medication safety. During long-term treatment, patients should regularly review their cognitive function and adjust the dosage based on efficacy and adverse reactions to avoid overdose or poor efficacy.

In terms of side effects, donepezil is generally well tolerated, but some adverse effects may still occur. The most common include nausea, vomiting, diarrhea, decreased appetite, weight loss, insomnia, headache and dizziness. Some patients may experience muscle spasms, joint pain, or weakness. Less common but serious side effects to be alert for include irregular heartbeat, sinus bradycardia, drop in blood pressure, seizures, or gastrointestinal bleeding. Therefore, the patient's blood pressure, heart rate, liver and kidney function, and hematological indicators should be closely monitored during the initial period of medication or during dose adjustment. Once severe discomfort or dangerous symptoms occur, seek medical attention immediately and consider adjusting or discontinuing the medication.

During the use of donepezil, attention should be paid to the safety of some specific groups of people. For patients with heart disease (such as arrhythmia, heart block, etc.), they should be used with caution or under the guidance of a cardiologist; patients with liver and kidney dysfunction need to adjust the dose according to their liver and kidney function; elderly patients are more sensitive to drugs and should start with a low dose and adjust slowly. At the same time, pregnant women and lactating women need to fully evaluate the pros and cons before use, and choose to discontinue the drug or alternative treatment if necessary. Drugs may interact with other central nervous system drugs, anticholinergic drugs, or gastrointestinal drugs, so patients should inform their doctor about all drugs they are taking.

Donepezil can be used alone or as part of a comprehensive treatment plan, combined with cognitive training, psychological intervention, and lifestyle management to achieve better results. In daily life, patients and their families should pay attention to observing cognitive functions, mood changes, sleep conditions and physical reactions, and follow up with doctors regularly. At the same time, following the doctor's medication instructions, taking the medication on time and in the right amount, and not increasing or decreasing the dose at will is the key to ensuring efficacy and safety. Long-term regular use of donepezil can delay the decline of cognitive function, improve quality of life, and enable patients to maintain better autonomy and social functions in daily life.

In short, donepezil, as one of the first-choice drugs for Alzheimer's disease, can improve cognitive function, alleviate behavioral and psychological symptoms, and improve patients' quality of life to a certain extent. During use, patients should strictly follow the official instructions and doctor's guidance to adjust dosage and monitor side effects, and combine comprehensive intervention measures to obtain the best therapeutic effect. At the same time, regular follow-up visits should be maintained to evaluate treatment response and ensure safe and scientific medication use. Although donepezil cannot cure the disease, with standardized use, it is still an important drug choice to improve patients' cognition and living abilities.

Reference materials:https://www.drugs.com/